Search

Learn about MSK’s expertise in treating vulvar and vaginal cancers, uterine sarcoma, uncommon ovarian cancers, and gestational trophoblastic disease.

… Friday, September 27, 2019 Summary Members of MSK’s gynecology oncology team are leaders in diagnosing and treating not only well-known gynecologic cancers but uncommon forms as well. In its annual listing of the country’s best hospitals,  U.S. News & World Report  ranked Memorial Sloan Kettering number

An epigenetic mechanism may make small cell lung cancer vulnerable to a new kind of attack.

… Monday, February 13, 2017 Summary Small cell lung cancer (SCLC) is notoriously difficult to treat because it quickly acquires resistance to chemotherapy. Scientists at Memorial Sloan Kettering have uncovered a molecular mechanism by which SCLC cells develop resistance, opening the door to new treatments

More than 10,000 people nationwide will participate in Memorial Sloan Kettering Cancer Center’s sixth annual Cycle for Survival event taking place this February at Equinox clubs in New York City, Long Island, Washington D.C., Chicago, San Francisco, and Los Angeles.

… Wednesday, February 1, 2012 More than 10,000 people nationwide will participate in Memorial Sloan Kettering Cancer Center’s sixth annual Cycle for Survival event taking place this February at Equinox clubs in New York City, Long Island, Washington D.C., Chicago, San Francisco, and Los Angeles. An indoor

Researchers discover why cancer immunotherapies often fail to finish the job.

… Monday, July 13, 2020 Summary Researchers find that changes in the metabolism of immune T cells cause them to lose their ability to attack cancer cells after initially recognizing them as a threat. Perhaps the biggest challenge facing cancer immunotherapy is figuring out why it doesn’t work for everyone

… Saturday, September 19, 2009 Twenty-four undergraduate students joined our community of scientists for ten weeks, working with faculty mentors who helped them to define and realize their research projects. The school welcomed our new class of PhD students, who have completed their first laboratory rotation

New findings from experiments done in mice suggest a surprising cause of common neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

… Wednesday, August 30, 2017 Summary Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are not well understood, and there are few effective treatments. A study from scientists at the Sloan Kettering Institute sheds light on the underlying causes of neurodegeneration and opens up new possibilities

Learn what you need to know about safety requirements for breast implants.

… Thursday, September 15, 2022 The U.S. Food and Drug Administration (FDA) reported on September 8 that a small number of cases of squamous cell carcinoma (SCC) had been found in the scar tissue of women with breast implants. The FDA is aware of fewer than 20 of these cases of SCC. While the finding appears

Early detection helps improve patient outcomes, but data shows that many cancers are going undiagnosed or untreated because of COVID-19.

… Thursday, January 28, 2021 On January 28, 2021, Memorial Sloan Kettering (MSK) and more than 75 national cancer centers and organizations endorsed an open letter from the National Comprehensive Cancer Network (NCCN) and the American Cancer Society (ACS) urging Americans to resume regular cancer screenings

Read highlights of research presented by MSK scientists at the annual ASH meeting.

… Monday, December 9, 2024 Research advances in lymphoma, leukemia, and multiple myeloma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the  American Society of Hematology (ASH) Annual Meeting , which runs December 7–10. Below are some highlights. Dual-Targeting of JAK

June’s “MSK Science Spotlight” segments kick off on Monday, June 1, featuring the honoree of the Katharine Berkan Judd Award Lectureship, Ron Vale, PhD, Vice President and Executive Director, Janelia Research Campus at the Howard Hughes Medical Institute.

… Monday, June 1, 2020 June’s “ MSK Science Spotlight ” segments kick off on Monday, June 1, featuring the honoree of the Katharine Berkan Judd Award Lectureship, Ron Vale, PhD, Vice President and Executive Director, Janelia Research Campus at the Howard Hughes Medical Institute. Dr. Vale will be presenting